Literature DB >> 22159117

Early improved and late defective cognition is reflected by dendritic spines in Tau.P301L mice.

Anna Kremer1, Hervé Maurin, David Demedts, Herman Devijver, Peter Borghgraef, Fred Van Leuven.   

Abstract

Cognitive demise correlates with progressive brain tauopathy in dementing patients. Improved cognition of young Tau.P301L mice contrasts with dysfunction later in life and remains unexplained (Boekhoorn et al., 2006). To unravel early mechanisms, we composed a correlative time line of clinical symptoms, cognitive defects, and biochemical and pathological traits, including comprehensive analysis of dendritic spines in specified regions of the cortex and hippocampus of young and adult Tau.P301L mice. Remarkably, young Tau.P301L mice have not more, but more mature spines than wild-type mice, revealing the anatomical substrate for their improved cognition and LTP. Spine maturation remained high in the hippocampus of adult Tau.P301L mice. However, spines regressed in length paralleling impaired cognition and increased Tau phosphorylation (Terwel et al., 2005). Conversely, spine maturation was unaffected in adult Tau.4R mice, while spine density was increased and length reduced similar to Tau.P301L mice. To explain how protein Tau promoted spinogenesis, we analyzed hippocampal synaptosomes and dendritic spines for mouse and human Tau. While synaptosomes were positive for both mouse and human Tau, weak variable reaction in spines was observed only after fixation according to Bouin. Mouse Tau was absent from spines in wild-type mice, dissociating the pathological actions of Tau in transgenic mice by relocalization into dendrites and spines from the physiological actions of protein Tau in axons only. We conclude that mutant protein Tau modulates cognition and morphology of spines similarly and in both directions, with pathology later in life coinciding with increased phosphorylation and relocalization of Tau from axons to soma and processes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22159117      PMCID: PMC6634152          DOI: 10.1523/JNEUROSCI.4859-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  44 in total

Review 1.  Dendritic spines: structure, dynamics and regulation.

Authors:  H Hering; M Sheng
Journal:  Nat Rev Neurosci       Date:  2001-12       Impact factor: 34.870

2.  Isoforms changes of tau protein during development in various species.

Authors:  Hiroshi Takuma; Shigeki Arawaka; Hiroshi Mori
Journal:  Brain Res Dev Brain Res       Date:  2003-05-14

Review 3.  Tau gene mutations: dissecting the pathogenesis of FTDP-17.

Authors:  Esther M Ingram; Maria G Spillantini
Journal:  Trends Mol Med       Date:  2002-12       Impact factor: 11.951

4.  Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain.

Authors:  D Moechars; I Dewachter; K Lorent; D Reversé; V Baekelandt; A Naidu; I Tesseur; K Spittaels; C V Haute; F Checler; E Godaux; B Cordell; F Van Leuven
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

5.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.

Authors:  K Spittaels; C Van den Haute; J Van Dorpe; K Bruynseels; K Vandezande; I Laenen; H Geerts; M Mercken; R Sciot; A Van Lommel; R Loos; F Van Leuven
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 6.  Tau pathology: a marker of neurodegenerative disorders.

Authors:  A Delacourte; L Buée
Journal:  Curr Opin Neurol       Date:  2000-08       Impact factor: 5.710

7.  Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.

Authors:  Dick Terwel; Reena Lasrado; Johan Snauwaert; Erno Vandeweert; Chris Van Haesendonck; Peter Borghgraef; Fred Van Leuven
Journal:  J Biol Chem       Date:  2004-10-27       Impact factor: 5.157

8.  Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice.

Authors:  K Spittaels; C Van den Haute; J Van Dorpe; H Geerts; M Mercken; K Bruynseels; R Lasrado; K Vandezande; I Laenen; T Boon; J Van Lint; J Vandenheede; D Moechars; R Loos; F Van Leuven
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

9.  Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP.

Authors:  G Feng; R H Mellor; M Bernstein; C Keller-Peck; Q T Nguyen; M Wallace; J M Nerbonne; J W Lichtman; J R Sanes
Journal:  Neuron       Date:  2000-10       Impact factor: 17.173

10.  Unhampered prion neuroinvasion despite impaired fast axonal transport in transgenic mice overexpressing four-repeat tau.

Authors:  Valerie Künzi; Markus Glatzel; Michel Y Nakano; Urs F Greber; Fred Van Leuven; Adriano Aguzzi
Journal:  J Neurosci       Date:  2002-09-01       Impact factor: 6.167

View more
  24 in total

1.  Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy.

Authors:  Johanna L Crimins; Anne B Rocher; Jennifer I Luebke
Journal:  Acta Neuropathol       Date:  2012-09-14       Impact factor: 17.088

2.  Soluble forms of tau are toxic in Alzheimer's disease.

Authors:  Katherine J Kopeikina; Bradley T Hyman; Tara L Spires-Jones
Journal:  Transl Neurosci       Date:  2012-09       Impact factor: 1.757

3.  Axodendritic sorting and pathological missorting of Tau are isoform-specific and determined by axon initial segment architecture.

Authors:  Hans Zempel; Frank J A Dennissen; Yatender Kumar; Julia Luedtke; Jacek Biernat; Eva-Maria Mandelkow; Eckhard Mandelkow
Journal:  J Biol Chem       Date:  2017-05-23       Impact factor: 5.157

4.  A tetra(ethylene glycol) derivative of benzothiazole aniline ameliorates dendritic spine density and cognitive function in a mouse model of Alzheimer's disease.

Authors:  Jung Min Song; Amanda Marie DiBattista; You Me Sung; Joo Myung Ahn; R Scott Turner; Jerry Yang; Daniel T S Pak; Hey-Kyoung Lee; Hyang-Sook Hoe
Journal:  Exp Neurol       Date:  2013-12-06       Impact factor: 5.330

5.  Synaptic alterations in the rTg4510 mouse model of tauopathy.

Authors:  Katherine J Kopeikina; Manuela Polydoro; Hwan-Ching Tai; Erich Yaeger; George A Carlson; Rose Pitstick; Bradley T Hyman; Tara L Spires-Jones
Journal:  J Comp Neurol       Date:  2013-04-15       Impact factor: 3.215

6.  Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation.

Authors:  Linn Hege Nilsen; Caroline Rae; Lars M Ittner; Jürgen Götz; Ursula Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-23       Impact factor: 6.200

Review 7.  Is tau ready for admission to the prion club?

Authors:  Garth F Hall; Brian A Patuto
Journal:  Prion       Date:  2012-07-01       Impact factor: 3.931

8.  Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau.

Authors:  Ann Van der Jeugd; Katja Hochgräfe; Tariq Ahmed; Jochen M Decker; Astrid Sydow; Anne Hofmann; Dan Wu; Lars Messing; Detlef Balschun; Rudi D'Hooge; Eva-Maria Mandelkow
Journal:  Acta Neuropathol       Date:  2012-04-25       Impact factor: 17.088

9.  Tauopathy differentially affects cell adhesion molecules in mouse brain: early down-regulation of nectin-3 in stratum lacunosum moleculare.

Authors:  Hervé Maurin; Claire Marie Seymour; Benoit Lechat; Peter Borghgraef; Herman Devijver; Tomasz Jaworski; Mathias V Schmidt; Sebastian Kuegler; Fred Van Leuven
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

10.  Neurological characterization of mice deficient in GSK3α highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinase.

Authors:  Hervé Maurin; Benoit Lechat; Ilse Dewachter; Laurence Ris; Justin V Louis; Peter Borghgraef; Herman Devijver; Tomasz Jaworski; Fred Van Leuven
Journal:  Mol Brain       Date:  2013-05-25       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.